Pulmonary Clinical Trials

California Pacific CURRENTS: The online journal of CPMC Research Institute

Below is a listing of Pulmonary Clinical Trials approved by CPMC’s Institutional Review Board:

 

Serum Biomarkers for FDG-PET Positive Lung Nodules

Description: Using blood biomarkers and PET imaging to improve care for the lung nodule and cancer patient. In collaboration with Stanford University's School of Medicine, this study will assess the application of new technologies for improving medical care by studying the application of blood based molecular markers in the context of currently available imaging techniques

Investigators

  • George Horng, MD

Eligibility Requirements

Male/Female subjects, 18 years or older, with a chest x-ray or computer tomography (CT) scan detected solitary pulmonary nodule that will be undergoing a PET scan

Status

Active and open to enrollment

Contacts

Anna von Bakonyi, LVN, 415-600-1107

 

 

Early Diagnosis of Pulmonary Nodules Using A Plasma Proteomic Classifier, Protocol Number 1001-12

Description: Early Diagnosis of Pulmonary Nodules

Investigators

  • George Horng, MD

Eligibility Requirements

Male/Female subjects, 50 years or older, who have a smoking history ≥ 20 pack-years

Status

Active and open to enrollment

Contacts

Anna von Bakonyi, LVN, 415-600-1107